Doxorubicin antibiotic produced by Streptomyces peucetius is a very crucial antibiotic with a large spectrum used as an anticancer drug and in clinical treatment. Production of doxorubicin from wild type strain by microbiological fermentation process is nomally very low yield and limited. The enhancement of doxorubicin production (DXR) by the genetically engineering of the auxiliary genes involved in the pathway of doxorubicin biosynthesis from Streptomyces peucetius has being focused by many research groups. The gene cluster responsible for biosynthesis of doxorubicin had been isolated, sequenced and characterized. Among them, the dnrQ and dnrS genes belong to the gene cluster encoded for the glycosyltransferase and helper enzymes, which are responsible for attachment of sugar moiety to -rhodomycinon intermediate and regulation of doxorubicin production, respectively. In this research, the dnrQ and dnrS genes were isolated and cloned in the p25.1 vector containing the strong promoter (ermE*) to generate the p25.1QS as a recombinant vector. The obtained plasmid was transferred into the host strain Streptomyces peucetius MH9.2 by the protoplast transformation method to generate the S. peucetius MH9.2SQ strain. Doxorubicin production from the recombinant S. peucetius MH9.2SQ and the parent strain were extracted and purified by using chlorofrom and methanol solvents. The products were confirmed by HPLC, LC-mass analysis and antibacterial bioassay. The results showed that the over production of doxorubicin was accumulated by the recombinant strain from the fermentation broth. In the S. peucetius MH9.2SQ, the doxorubicin productivity was 3.1 to 3.6 folds higher than in the parent strain. This recombinant strain could be a potential candidate for further research in enhancement and larger biomass scale of DXR production.
INTRODUCTION
Doxorubicin (DXR) (adriamycin or 14-hydroxydaunorubicin) is an anthracycline antibiotic produced from Streptomyces peucetius ATCC 27952 and used in chemotherapy for treatment of various cancers. DXR was first isolated and studied by the Arcamone group (Arcamone et al., 1997) . The wild type strain is nomaly to produce very low yield (2 mg.l -1 ) due to very toxic compound and it causes the death for host cell (Mallar et al., 2010) . To improve the production of doxorubicin, many researchers have had efforts to study the biosynthesis pathway and the gene regulation for higher yield of DXR by genetical modification and recombinant methods of wild type strain. Many of the published studies on the enhancement of secondary metabolites have focused either on the over expression of one positive regulator or by the deletion of one negative regulator at a time. Two classes of regulatory genes were reported as pathway specific and global regulatory involved in the production of secondary metabolites (Chater et al., 1996) . Some other regulatory genes generally located outside the biosynthetic gene cluster may play a regulatory role in the cluster showing effects on the production of multiple secondary metabolites. Over expression of regulators increase the production of different secondary metabolites such as actinorhodin in S. coelicolor by actII-orf4 and redD (Narva et al., 1990; Fernández-Moreno et al., 1991) , nikkomycin in S. ansochromogenes by sanG (Liu et al., 2005) , clavulanic acid in S. clavuligerus by ccaR (Hung et al., 2007) . Doxorubicin biosynthesis gene cluster had been isolated and sequenced, among them the dnrS and dnrQ genes play a very crucial role for the post biosynthesis doxorubicin as glycosylation step. The gene dnrS encodes for glycosytransferase and is responsible for the attachment of deoxysugar 2,3,6-trideoxy-3-aminohexose, daunosamine to the rhodomycinone core (Dreier et al., 2007; Jiang et al., 2006) . The gene dnrQ encodes the auxiliary protein to help the activity of DnrS and for the complement of DnrQ/S activity (Fig. 1) . In addition, glycosyltransferase and auxiliary gene have thought to act as regulator for the enhancement of production. The expression of dnrS or dnrQ separately had not given any positive regulation for the DRX production. However, the over expression together of dnrS/Q led to remarkably increase the DRX amount in the S. peucetius host cells via in vivo experiment (Sharee et al., 1995; Sailesh et al., 2009) .
The aim of this study was to develop recombinant strains of S. peucetius which are improved DXR production by the genetic engineering dnrS/dnrQ. The genes were cloned and expressed in the S. peucetius host cells. The screening process is to better understand that the dnrQ and dnrS works as regulation role for higher amount of DXR and the selection the engineered S. peucetius as potentical candidate used in the production on scale.
MATERIALS AND METHODS

Materials
DXR standard was provided by the Genechem Co. (Daejeon, Korea). HPLC grade methanol was acquired from Mallinckrodt Baker (Phillipsburg, NJ, USA). The PCR premix (Genotech, Korea) was used for the preliminary screening or optimizing the PCR conditions. Glucose, 22.5 g; Difco yeast extract, 5.04 g; NaNO3, 4.28 g; K2HPO4, 0.23 g; HEPES, 4.77 g; MgSO4.7H2O, 0.12 g; NaOH, 0.4 g; trace element solution; PEG, thiostrepton antibiotics, and other chemicals for experiment were purchased from Sigma Co. Ltd. S. peucetius MH9.2, S.peucetius wild strains supported from the Central of Research and Applied Biotechnology, Ha Noi Open University was used as a parental strain.
Methods
DNA manipulation, gene cloning and polymerase chain reaction (PCR)
Standard methods were used for DNA cloning, plasmid isolation, and restriction enzyme digestion followed by Kieser's protocol (Kieser et al., 2000) . The nucleotide sequences were analysed by using DNA strider. Potential open reading frames (ORFs) were identified using Frame Plot (Sambrook et al., 2001) , and were searched for homologies using NCBI BLAST server (www.ncbi.nlm.nih.gov/BLAST/).
Oligonucleotide primers for the amplification of desired ORFs using a thermo cycler (Takara) used in this study are summarized in Table 1 . The reaction mixture contained 20 pM primers, 0.125 mM deoxynucleotide triphosphates (dNTPs), 10% dimethyl sulfoxide (DMSO), appropriate amount of template DNA, 2 unit of La Taq polymerase, 2.5 mM MgCl2, in the PCR buffer supplied with enzyme. The PCR conditions: denaturation temperature at 94ºC for 7 min then followed by 30 cycles of 94ºC for 1 min, annealing temperature range from 55ºC to 68ºC for 1 min depending upon the PCR primers and the template and 72ºC for 1 min; and 72ºC for 10 min for the last extension cycle. Table 1 . Primers for PCR.
Name
Sequence Restriction site
Construction of expression plasmid p25.1SQ
Isolation and purification of dnrS and dnrQ
To amplify the dnrS (1296 bp) and dnrQ (1317 bp) from S. peucetius genomic DNA, the PCR process was carried out as protocol described above. The primers dnrQ-F/dnrQ-R were used for cloning dnrQ; dnrS-F/dnrS-R used for cloning dnrS gene. The PCR products of dnrQ and dnrS were digested by EcoRI/BamHI and PstI/HindIII respectively, which were then cloned into the cloning vector with high copy number, namely, pGEM-3Z(+) producing the pGEM-QS vector containing dnrQS fragment for the further other analysis and experiments. All of the PCR products were cloned into pGEM-T vector (Promega, USA) and sequenced prior to cloning into the expression vector to verify that no mutations had been introduced during the PCR amplification.
Cloning dnrS and dnrQ into p25.1 vector
Originally, the transformation into Streptomyces cell has been challenged many research groups, so iBR25 vector was constructed as a special vector used to transform into Steptomyces cells (the size 7.5kb). Vector modified p25.1 (9.7kb) has been completely created which is bared desIII and desIV genes form S. venezuela genome and strong promotor isolated from Erythromycin gene cluster. The desIII and desIV genes are functioned as participating in the deoxysugar biosynthesis of antibiotics and increasing the antibiotic biosynthesis production (Thuy et al., 2014) .
Protoplast transformation and screening
For protoplast transformation, regeneration, and DNA transformation were slightly modified from the methods of Kieser et al. (2000) and followed by Sailesh's protocol (Sailesh et al., 2010) . S. peucetius was grown in a 500 ml baffled flask containing 50 ml R2YE medium at 28°C for 48 -60 hrs. Mycelia were harvested by centrifugation and washed with 10.3% sucrose then with P-buffer. The protoplast and mycelia mixture were filtered through cotton plug to remove cell debris. The protoplasts were gathered by centrifugation and washed twice with P-buffer. A 125 µl of protoplasts were treated with 0.1 mM aurintricarboxylic acid (ATA) for 10 min and 12 µl to 15 µl of plasmid DNA was added. Immediately, 200 µl of 40% (wt/vol) polyethylene glycol 1000 (PEG) solution was added and then, centrifuged briefly to remove PEG. These transformed protoplasts were plated in R2YE regeneration plate, and was incubated at 28°C for 24 hrs. The lawn colonies were overlaid by 0.3% agar solution containing appropriate antibiotics (20 -100 µg ml -1 thiostrepton). After overlaying, selected colonies were screened on growing media with antibiotics as per the required condition.
Production of DRX by engineered strain
The S. peucetius engineered strains were inoculated into 50 ml NDYE-glucose medium [(per liter) glucose 22.5 g; Difco yeast extract 5.04 g; NaNO3 4.28 g; K2HPO4 0.23 g; HEPES 4.77 g; MgSO4·7H2O, 0.12 g; NaOH 0.4 g; and trace element solution, 2 ml] at 28°C and 230 rpm. After 48 h of incubation, 1 ml of seed culture was transferred to 50 ml of NDYE-maltose medium, which comprises of (per liter) Difco maltose, 22.5 g instead of glucose in NDYE-glucose medium. The incubation was carried out at 28°C and 230 rpm for 5 days.
Isolation of doxorubicin from fermentation broth
Aliquots of culture broth containing mycelia were extracted with twice volume of chloroformmethanol (9:1) (Parajuli et al., 2005) . The extracted solvents were evaporated until dryness by the method of rotary evaporator. Thus obtained residue extract was reconstituted in 1 ml of methanol and subsequently subjected to HPLC and LC-MS analysis. For the comparison of DXR production, 1 ml culture media of broth strains were extracted with double volume of the mixture of chloroform: methanol (9:1) after 84, and 96 h of incubation. The extraction-solvent was evaporated in vacuumm and dissolved in 50 μl of methanol. A 15-20µl sample of the extract was injected to HPLC.
Analysis of DXR production
The HPLC analyses were performed by injecting 15 μl of extracts sample fitted with a Mightysil RP-18 GP column (4.6 x 250nm x 5 μm, Kanto Chemical Tokyo). The elution was carried out with water (at pH 2.3 by trifluoro acetic acid) at the flow rate of 1 ml min -1 by the following method: 0-50 min (0-100% B), 50-60 min (100% B) and 60-70 min (100% A). Detection was carried out by UV light absorption at 254 nm wavelengths. Authentic DXR and DNR were taken as reference.
The HPLC standard cover of doxorubicin was used for the quantity analysis which was set up with the range of doxorubicin concentration from the 100, 200, 300, 400, and 500 µg.ml -1 (Table 2) .
Antibacterial assay
Bacillus subtilis was used for test of antibacterial activity. Specifically, 5 μl aliquots of the chloroform-methanol whole-cell extracts were added to paper discs and placed on a lawn of test strain (B. subtilis) overlaid onto nutrient agar plates. The plates were incubated at 37°C overnight. The antibacterial activity of the secondary metabolites was observed by the appearance of the diameter of clear inhibition zones surrounding the paper disc. Methanol was used as negative control. 
RESULTS AND DISCUSSION
Isolation and sequence analysis of dnrS and dnrQ
The dnrS and dnrQ genes were amplified by the PCR method as described in the protocol above (Materials and Method). All of the PCR products were cloned into pGEM-T vector (Promega, USA) and sequenced prior to cloning into the expression vector to verify that no mutation had been introduced during the PCR amplification. The open reading frame dnrQ (1,317 bp) flanked by dnrS (1,296 bp) are located within the doxorubicin biosynthesis gene cluster downstream of the polyketide synthase (PKS) genes. The dnrQ and dnrS genes were flanked upstream by dnrP and downstream by dnrC. Using the ClustalW program, the determined sequence analysis of these genes revealed a deduced amino acid sequence of dnrS (432 aa) that encodes glycosyltransferase and showed a very high degree of similarity to a number of the known GTs in the GenBank, including GT from Streptomyces prasinopilosus (94% identity) (GenBank accession no. WP_055571862.1); glycosyltranferase from Streptomyces sp. ScaeMP-e83 (87% identiy) (GenBank accession no WP_093692494.1); and GT from Streptomyces kasugaensis (61% identity) (GenBank accession WP_094791596.1). In addition, analysis of the amino acid sequences of dnrQ encoded for the auxilary protein to help the activity of dnrS that show high similarity to protein helper of Streptomyces prasinopilosus (GenBank Accession no. WP-055693204.1); activator protein from Streptomyces sp. ScaeMP-e83 (GenBank accession no. WP_093692495.1).
Construction of expression plasmid p25.1SQ
To construct recombinant expression plasmid, the 2.5 kb DNA fragment containing the dnrSQ was digested by EcoRI/HindIII from the pGEM-SQ vector and the cloned into modified p25.1 vector digested with the same restriction enzymes as well as by the ligation reaction.
The screening process was carried out by the transformation of ligation mixture into E.coli XLblue and growing in the Apramycin antibiotic medium for the selection of correct colonies which are bearing the expression plasmid containing dnrQS fragment named p25.1SQ. Finally, the obtained recombinant expression plasmid p25.1SQ was examined for the correct clone by restriction enzyme digestion (EcoRI/HindIII). The bands of DNA running in the agarose electrophoresis have shown the correct clone of the dnrQS (2.6 kb) into the expression plasmid (9.7 kb).
The appropriated conditions for transformation of p25.1.SQ into S. peucetius MH9.2
The plasmid was firstly propagated into E. coli ET-12567 host to get demethylated plasmid DNA and to get of risk the degradation of foreigner DNA. Then isolated plasmid from E. coli ET was transformed into S. peucetius MH9.2 host by using PEG-mediated protoplast transformation. For screening process, the transformed protoplast mixture was plated onto the R2YE medium. The plates were overlaying with 20 -1000 µg.ml -1 thiostrepton (tsr) after exactly 20 hrs of inoculation. The correct recombinant strains which is harbored the expression plasmids named as S. peucetius MH9.2QS) were selected by showing growing and resistant thiostreptone resistance.
The factors, have effects on the transformation yield, include concentration of PEG, the time period for lysozyme inoculation and thiostreptone antibiotic overlaying after transformation. The results have shown that there was very high growth rate but no transformation occurred if the antibiotic, PEG and lysozyme were applied at very low concentration. In contrast, all cell deaths were observed when those condition and concentration increased. The best condition for transformation was discovered for recombinant strain including 80 mg.mg -1 tsr, 40% v.v PEG and lysozyme inoculation for 50 min, respectively (Table 3) . For the preliminary analysis of production from recombinant strain, the fermentation of the recombinant was carried out for 84 hrs and the host strain as control sample was culture for 60 hrs, 72 hrs, 84 hrs and 96 hrs, respectively. The solvent system of CHCl3:MeOH was applied to the whole cell extracts, then extraction was centrifuged to remove the medium and collect the solvent containing crude doxorubicin extraction. The TLC and bioassays analysis were performed. TLC analysis indicated that S. peucetius p25.1 QS produced doxorubicin compound in higher amount in comparison with the S. peucetius MH9.2 (Fig.  2B) . Similarly the bioactivity test of the compounds indicated the greater inhibition zone in case of S. peucetius 25QS than S. peucetius MH9.2 ( Fig. 2A) .
Analysis of DXR production from engineered strain
To test the level accumulation of doxorubicin, four colonies of S. peucetius MH9.2QS recombinant strains and MH9.2 as control strain were selected for analysis and measuring DXR production. The fermentation of strains in the production medium (NDYE) were carried out for biomasses of both recombinant and parental strains.
The HPLC and LC-mass analysis of the isolated doxorubicin product from the recombinant strain have shown the significant amount increased more than three times in comparison with parental strains. HPLC profile showed the compound having molecular ion with peak at a retention time of 32.5 min in HPLC (Figs. 3A, 3B, 3C ). The amount of doxorubicin produced by recombinant strains, which were calculated in the biomass fermentation, was from 6.8 to 7.25 mg.l -1 . Meanwhile the amount produced by the parental strain was only 2.3 mg.l -1 (Table 4) .
Profile with m/z = 544.6 [M+H + ] in LC-ESI/MS analysis which corresponded to DXR (calculated mass 543.53). Identification of DXR was also verified by comparison with standard (Figs. 4A, 4B) . The results indicated that the DXR productivity was enhanced more by over expression of the cognate GT pairing of dnrS/dnrQ in the host strain S. peucetius. The recombinant strain could be potential for the other phase research. 
CONCLUSION
Over production of doxorubicin from recombinant strain by genetically engineering, in which the dnrQ and dnrS genes were cloned into p25.1 and then transformed into the host S. peucetius MH9.2, has given the significant effect on DXR biosynthesis. The production of DXR was enhanced up to 7.3 mg l -1 (3.5 folds if compared to parental strain) whereas, the parental strain produced 2.2 mg l -1 . The strain S.p.MH9.2QS has the higher titers of DXR because of higher TDP-L-daunosamine pool and efficient glycosylation and to reduce the toxic nature of DXR against cell itself.
